Sunday, November 18, 2018 12:06:45 AM
1. They cant file anything because they can't afford it,
2. They can't raise the stock price because they can't become current,
3. A reverse split will achieve nothing because there is next to no outside interest / investor confidence here,
4. To convert the notes payable at this level would be corporate suicide since the fiscal dilution would be irreparable.
5. The only real answer is to "Go Grey" and lay low until clinical trials are done and then Peters, Chicoski, and Katzaroff can drum up interest and equity for a private placement (that is the entire reason this board was brought in in the first place, especially Katzaroff). And Peters role is to use his Washington insider status to grease the wheels of government to get the FDA to grant a form 510-K.
If I were a majority shareholder *cough Groman cough* I would be hounding the board to get going on step 5 or be shown the door and bring in better people. Also, one would assume Peters can pay these filing fees out of pocket since if the guy has enough time and money to run for Congress he has enough time and money to file some SEC docs for a small company like this.
Thanks
- DB
Recent VNTH News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 09:30:06 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM